EUVIMEDEUVIMED entdecken
Crossref

Antimicrobial Peptide Design, Molecular Docking and ADMET Studies Against the Methicillin-Resistant Staphylococcus aureus and Carbapenem-resistant and Carbapenemase-producing Pseudomonas aeruginosa: Prediction of novel anti-MRSA and anti-CRPA AMPs

Abdulmalik Aliyu, Yakubu K.E. Ibrahim, Babajide Akinyele Tytler, Ahmed Olowo‐okere

Trends in Peptide and Protein Sciences · 02.11.2022

DOI: 10.22037/tpps.v7i.39110 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Trends in Peptide and Protein Sciences, erschienen am 02.11.2022. Verfasst von Abdulmalik Aliyu und 3 weiteren Autor:innen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Carbapenem-resistant and carbapenemase-producing Pseudomonas aeruginosa (CRPA) and methicillin-resistant Staphylococcus aureus (MRSA) are two pathogens that are resistant to currently available antimicrobials. As an alternative to effective medication molecules, antimicrobial peptides (AMPs) have the potential to cure superbug-caused infections effectively. Two new AMPs (ama1 and ama2) were designed utilizing a knowledge-based technique with optimal parameters. First, the PEP-FOLD 3.5 server made a de novo prediction of the AMPs' three-dimensional (3D) structure, which was validated using PROCHECK of SAVES v6.0 by checking the amino acid locations in the Ramachandra plot. Then, protein-peptide docking simulations of the predicted AMPs and reference AMP (Aurein 1.2) for positive control were performed using the HPEPDOCK docking web server, followed by the computation of the AMPs' physicochemical parameters and toxicity profile using the ProtParam and vNN-ADMET web servers, respectively. The sequences for ama1 and ama2 were AWGKIKALR and IKWLRLAKP, respectively. Docking analysis revealed that the antibacterial activity of ama1 and ama2 was superior to that of Aurein 1.2 against CRPA-resistant enzyme (6ew3), respectively. However, ama1, ama2, and Aurein 1.2 inhibited the activity of MRSA-resistant protein (4c12). Both the physicochemical qualities and the toxicity profiles were advantageous. Therefore, the in-silico-derived AMPs could serve as a pharmaceutical candidate for developing multidrug-resistant bacteria-effective antimicrobials. HIGHLIGHTS Two cationic antimicrobial peptides (AMPs) were designed. Molecular docking of the AMPs revealed better antimicrobial activity than the reference. The novel AMPs had net positive charge and optimal hydrophobic amino acids.

Schlagwörter

antimicrobial peptidesantimicrobial peptide designmethicillin-resistant Staphylococcus aureuscarbapenem-resistant Pseudomonas aeruginosacarbapenemasemultidrug-resistant bacteriaprotein-peptide dockingaurein 1.2physicochemical propertiestoxicity prediction

Zitieren

APA

Aliyu, A., Ibrahim, Y. K., Tytler, B. A., & Olowo‐okere, A. (2022). Antimicrobial Peptide Design, Molecular Docking and ADMET Studies Against the Methicillin-Resistant Staphylococcus aureus and Carbapenem-resistant and Carbapenemase-producing Pseudomonas aeruginosa: Prediction of novel anti-MRSA and anti-CRPA AMPs. Trends in Peptide and Protein Sciences. https://doi.org/10.22037/tpps.v7i.39110

Vancouver

Aliyu A, Ibrahim YK, Tytler BA, Olowo‐okere A. Antimicrobial Peptide Design, Molecular Docking and ADMET Studies Against the Methicillin-Resistant Staphylococcus aureus and Carbapenem-resistant and Carbapenemase-producing Pseudomonas aeruginosa: Prediction of novel anti-MRSA and anti-CRPA AMPs. Trends in Peptide and Protein Sciences. 2022. doi:10.22037/tpps.v7i.39110

BibTeX
@article{Aliyu2022,
  author = {Aliyu, Abdulmalik and Ibrahim, Yakubu K.E. and Tytler, Babajide Akinyele and Olowo‐okere, Ahmed},
  title = {Antimicrobial Peptide Design, Molecular Docking and ADMET Studies Against the Methicillin-Resistant Staphylococcus aureus and Carbapenem-resistant and Carbapenemase-producing Pseudomonas aeruginosa: Prediction of novel anti-MRSA and anti-CRPA AMPs},
  journal = {Trends in Peptide and Protein Sciences},
  year = {2022},
  doi = {10.22037/tpps.v7i.39110}
}
Kostenlos starten →